Profiles: Page 3

The latest opinion pieces by industry thought leaders


  • A portrait of Matt Clark framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Matt Clark

    Tech Wizards: Matt Clark

    X-Chem’s CEO has pioneered DNA-encoded libraries to revolutionize small molecule discovery.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Mary-Ann Etiebet framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Mary-Ann Etiebet

    DE&I Champions: Dr. Mary-Ann Etiebet

    Merck’s associate vice president of health equity is making DE&I a part of the pharma giant's day-to-day strategy.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Mark Sullivan framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Mark Sullivan

    DE&I Champions: Mark Sullivan

    Medicines Development for Global Health’s founder is committed to eliminating neglected tropical diseases around the world.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Mark Goldberg framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Mark Goldberg

    Legacy Leaders: Dr. Mark Goldberg

    The savvy clinical trials pro has built a global CRO by targeting the needs of the industry’s bustling biotech sector.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Lori Abrams framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Lori Abrams

    DE&I Champions: Lori Abrams

    The VP of patient advocacy and clinical research diversity at WCG is shaking up the trial space by shining a light on underserved populations.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Lisa Walters-Hoffert framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Lisa Walters-Hoffert

    Entrepreneurs: Lisa Walters-Hoffert

    Daré Bioscience’s CFO and co-founder is determined to rapidly advance innovations in women’s health.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Laxmi Bonagiri framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Laxmi Bonagiri

    DE&I Champions: Laxmi Bonagiri

    EClinical Solutions’ VP of India operations is creating a path to increase the number of women in senior leadership roles while changing the course of diseases for millions.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Laurent Levy framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Laurent Levy

    Disrupters: Laurent Levy

    Nanobiotix’s co-founder is applying the principles of nanophysics to fight cancer with a universal mechanism of action.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Laura Niklason framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Laura Niklason

    Entrepreneurs: Dr. Laura Niklason

    The founder, president and CEO of Humacyte is turning science fiction into regenerative medicine reality.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of LaQuinta Jernigan framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by LaQuinta Jernigan

    DE&I Champions: LaQuinta Jernigan

    The chief operating officer and ‘face’ of mdgroup is a leading voice in the efforts to diversify clinical trials.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Kunal Ghosh framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kunal Ghosh

    Tech Wizards: Kunal Ghosh

    The leader of Inscopix embodies a 'bootstrap' approach to entrepreneurship, from soldering early versions of the Inscopix technology to taking a 'science-first' approach to fundraising.

    Alexandra Pecci • Sept. 6, 2022
  • A portrait of Kuldeep Singh Rajput framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kuldeep Singh Rajput

    Entrepreneurs: Kuldeep Singh Rajput

    Bringing digital solutions to Big Pharmas adapting to a more patient-centric age, the CEO and founder of Biofourmis has instituted a flexible approach that keeps its tech on the leading edge.

    Michael Gibney • Sept. 6, 2022
  • A portrait of Kim Johnson framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kim Johnson

    Legacy Leaders: Kim Johnson

    The Global CEO is breathing fresh air into Ogilvy Health as she blazes a new trail at the storied agency.

    Alexandra Pecci • Sept. 6, 2022
  • A portrait of Dr. Kerry Blanchard framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Everest Medicines

    Legacy Leaders: Dr. Kerry Blanchard

    The former CEO of Everest Medicines has focused on breaking new ground for China-based innovation.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Kathy Lee-Sepsick framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Kathy Lee-Sepsick

    Entrepreneurs: Kathy Lee-Sepsick

    Kathy Lee-Sepsick, the founder of Femasys, is determined to change the game in long-neglected areas of women’s healthcare, some of which haven’t had much innovation in more than a century.

    Alexandra Pecci • Sept. 6, 2022
  • A portrait of Karin Jooss framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Karin Jooss

    Innovators: Karin Jooss

    The EVP and head of R&D at Gritstone bio is using her decades as a visionary drug developer to help the company advance vaccines for cancer.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Julie Kim framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Julie Kim

    Disrupters: Julie Kim

    The president of Takeda’s U.S. business unit and U.S. country head has steered through the pandemic, turning her aptitude for bringing people together into a master class in perseverance.

    Michael Gibney • Sept. 6, 2022
  • A portrait of Dr. Jordan Schecter framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Jordan Schecter

    Innovators: Dr. Jordan Schecter

    The VP of cellular therapy at Janssen has used collaboration, creative thinking and pragmatism to create a CAR-T multiple myeloma breakthrough.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Jonathan Steckbeck framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jonathan Steckbeck

    Disrupters: Jonathan Steckbeck

    The CEO, founder and president of Peptilogics is changing the game for the peptide medicine space with a promising pipeline and a disruptive discovery platform.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Dr. Jonathan Ng framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Jonathan Ng

    Tech Wizards: Dr. Jonathan Ng

    As CEO of Iterative Scopes, Dr. Jonathan Ng is relentlessly committed to health equity while leveraging AI to establish new standards of care for detection and treatment of GI diseases.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Johnna Wesley framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Johnna Wesley

    Innovators: Johnna Wesley

    The vice president of Type 1 diabetes and kidney disease research at Novo Nordisk is leading the charge to deliver paradigm-changing breakthroughs in the space.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of John Tsai framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by John Tsai

    Innovators: Dr. John Tsai

    How the former president of global drug development and chief medical officer at Novartis funneled his curiosity for engineering into a bold new approach to drug development.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of John Oyler framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by John Oyler

    Entrepreneurs: John Oyler

    The CEO of BeiGene is using innovative business strategies to help the oncology biotech quickly hit new heights.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Jim Doherty framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jim Doherty

    Innovators: Jim Doherty

    Sage Therapeutics’ chief development officer is leveraging innovative development strategies to create success against hard-to-treat brain disorders.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Jim Anthony framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jim Anthony

    Disrupters: Jim Anthony

    With a ready-for-anything attitude and a knack for relationship-building, the executive vice president and global head of Parexel Biotech is growing the CRO with a patient-first approach.

    PharmaVoice staff • Sept. 6, 2022